Goldman Sachs Initiates Coverage On Sotera Health with Buy Rating, Announces Price Target of $20

Goldman Sachs analyst Evie Koslosky initiates coverage on Sotera Health (NASDAQ:SHC) with a Buy rating and announces Price Target of $20.